Other
Register now: Aug. 13, 2025 - PACE/State of FL - The critical role of pharmacogenomics and therapeutic drug monitoring (TDM) in managing immunosuppressive therapy for solid organ transplant recipients.
Presentation Recording Coming Soon – PACE/State of FL - Critical topics essential for laboratory billing, coding, and compliance.
Presentation Recording Coming Soon - PACE/State of FL - How artificial intelligence and digital pathology have the potential to revolutionize the clinical laboratory landscape.
PACE/State of FL - The role of cytology specimens in molecular genetic testing, emphasizing their effectiveness in identifying biomarkers critical for targeted therapies in patients with cancer.
PACE/State of FL - This webinar will discuss the advantages of using electrophysiology results to guide the selection of axonal or demyelinating testing for peripheral neuropathy. This approach can help identify specific antibodies associated with the condition, providing a more precise diagnosis, and improving patient outcomes. Accurate diagnosis is crucial for effective treatment, as the therapeutic approach varies based on the underlying cause of peripheral neuropathy.
PACE/State of FL - The latest ASCO guidelines for selection of germline genetic testing panels for cancer patients.
P.A.C.E./Florida - Implementation of new analyzers and replacement of automation equipment in the Central Clinical Laboratory at Mayo Clinic in Rochester, Minnesota, prompted the laboratory to reassess blood collection volumes for commonly ordered tests.
PACE/State of FL - What problem-solving thinking is, as well as an overview of what DMAIC, A3, and PDSA problem-solving approaches are to support your quality and continuous improvement journey.
PACE/State of FL - This webinar will provide a methodology for laboratory leadership to review their test menu for assays that most impact the financial health of their laboratory.
Identification of early-onset IBD patients may enable tailored treatment and surveillance plans. With over 50 genes implicated in early-onset IBD, genetic testing should be included in the workup of children under the age of six with IBD. Join Mayo Clinic, in this “Specialty Testing” webinar, for a discussion of this testing and its clinical application.
The spectrum of autoimmune movement disorders, diagnosis and treatment.
PACE
In this month’s “Virtual Lecture” Eoin Flanagan, M.D., B.Ch., reviews how to diagnose autoimmune encephalitis, what to watch that may suggest a different diagnosis, discuss neural autoantibodies interpretation and putting test results into clinical context.
The considerations physicians must weigh when evaluating suspected neuropathy patients with special emphasis put on small-fiber neuropathy and the most appropriate laboratory testing related to that phenotype.